TONYA HARVEY: Open Payments
NPI 1528392156 · GARY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,297 in 61 payments from 17 companies in 2025. Trend: 2023 $1,547 · 2024 $2,309 · 2025 $2,297
Food & beverage: $2,297
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 15 | $515 |
| AstraZeneca Pharmaceuticals LP | 5 | $398 |
| ABBVIE INC. | 13 | $303 |
| Eisai Inc. | 5 | $282 |
| Kowa Pharmaceuticals America, Inc. | 1 | $121 |
| Teva Pharmaceuticals USA, Inc. | 1 | $105 |
| Phathom Pharmaceuticals, Inc. | 1 | $100 |
| Melinta Therapeutics, LLC | 1 | $94 |
| Novo Nordisk Inc | 4 | $72 |
| Xeris Pharmaceuticals, Inc. | 3 | $59 |
Products named: FREESTYLE LIBRE 3, Leqembi, BREZTRI, FARXIGA, EMBLAVEO, ZORYVE, UZEDY, VOQUEZNA.
Industry payments across IN — which companies pay providers there.
